carotuximab - CISMeF

Preferred Label : carotuximab;

MeSH note : an antineoplastic agent in phase I clinical trials (2013);

CISMeF synonym : TRC105;

MeSH hyponym : TRC-105;

Is substance : O;

UNII : YB2EWE6139;

Détails

Origin ID

C579557;

UMLS CUI

C4727597;

Currated CISMeF NLP mapping
- Carotuximab [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
Record concept(s)
- C-SN6J [MeSH concept]
- DE-122 [MeSH concept]
- TRC105 [MeSH concept]
- carotuximab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Carotuximab [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients